This is consistent with the cell cycle alterations, mostly G2 arrest, detected in CDK7-targeted cells and point to CDK7 inhibition as an effective strategy to block functionally the CDK7-CDK1 axis in HNSCC, observations that could probably be extrapolated to other tumor types. The gene discussed is CDK7; the disease is head and neck squamous cell carcinoma.